4-173527393-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000359562.4(HAND2):c.556-18C>G variant causes a intron change. The variant allele was found at a frequency of 0.0124 in 1,563,460 control chromosomes in the GnomAD database, including 182 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0087 ( 11 hom., cov: 32)
Exomes 𝑓: 0.013 ( 171 hom. )
Consequence
HAND2
ENST00000359562.4 intron
ENST00000359562.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.00
Genes affected
HAND2 (HGNC:4808): (heart and neural crest derivatives expressed 2) The protein encoded by this gene belongs to the basic helix-loop-helix family of transcription factors. This gene product is one of two closely related family members, the HAND proteins, which are asymmetrically expressed in the developing ventricular chambers and play an essential role in cardiac morphogenesis. Working in a complementary fashion, they function in the formation of the right ventricle and aortic arch arteries, implicating them as mediators of congenital heart disease. In addition, this transcription factor plays an important role in limb and branchial arch development. [provided by RefSeq, Jul 2008]
HAND2-AS1 (HGNC:48872): (HAND2 antisense RNA 1) Predicted to be involved in positive regulation of gene expression. Predicted to act upstream of or within with a positive effect on cardiac right ventricle morphogenesis. Predicted to act upstream of or within transcription elongation from RNA polymerase II promoter. Predicted to be located in chromatin; cytoplasm; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 4-173527393-G-C is Benign according to our data. Variant chr4-173527393-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 1331143.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1318 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAND2 | NM_021973.3 | c.556-18C>G | intron_variant | ENST00000359562.4 | NP_068808.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAND2 | ENST00000359562.4 | c.556-18C>G | intron_variant | 1 | NM_021973.3 | ENSP00000352565 | P1 | |||
HAND2-AS1 | ENST00000512099.5 | n.124G>C | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
HAND2 | ENST00000503024.1 | c.179-18C>G | intron_variant, NMD_transcript_variant | 3 | ENSP00000427084 |
Frequencies
GnomAD3 genomes AF: 0.00866 AC: 1318AN: 152158Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
1318
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00857 AC: 2132AN: 248852Hom.: 11 AF XY: 0.00858 AC XY: 1156AN XY: 134736
GnomAD3 exomes
AF:
AC:
2132
AN:
248852
Hom.:
AF XY:
AC XY:
1156
AN XY:
134736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0128 AC: 18098AN: 1411184Hom.: 171 Cov.: 24 AF XY: 0.0124 AC XY: 8743AN XY: 705064
GnomAD4 exome
AF:
AC:
18098
AN:
1411184
Hom.:
Cov.:
24
AF XY:
AC XY:
8743
AN XY:
705064
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00866 AC: 1318AN: 152276Hom.: 11 Cov.: 32 AF XY: 0.00806 AC XY: 600AN XY: 74466
GnomAD4 genome
AF:
AC:
1318
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
600
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at